Hyderabad, AP (PRWEB) July 17, 2012
Global Biodegradable Stents market is projected to grow at a CAGR of about 70% through the analysis period 2015-2020. With research trials becoming effective, and products pending approval, biodegradable stents will have a commercial market very soon.
Stent implantation is now regarded as an effective procedure for stenosis of blood vessels that are not acquiescent to balloon angioplasty. The medical field has seen remarkable improvement in stent design from the primitive Palmaz stent to the modern bioabsorbable and growth stents. The avenue open for future design development is with regard to suitability for treatment of CHD and further improvement to ensure biocompatibility that totally forbids restenosis and hyperplasia of intima. The major constraint in the use of stents for CHD patients is the paucity of number of patients on whom clinical trials can be performed. If these issues are solved by developing multinational registries of CHD patients, then stent implantation may alleviate the sufferings of innumerable CHD patients worldwide.
This latest market research gives an insight into Global Stents and Biodegradable Stents market. The report also provides a market overview of the Worldwide Bare Metal Stents and Drug Eluting Stents market. Market analytics for Biodegradable Stents by Application and by Biodegradable Material is provided in this niche report. The market is divided by Application into Coronary Arterial Stents, Peripheral Arterial Stents and Other; and by Biodegradable Material into Polymer and Metal. Major companies and their biodegradable stent products are discussed that include - Abbott Vascular (USA) ; Biotronik SE & Co. KG (Germany) ; Kyoto Medical Planning Co., Ltd. (Japan) ; Reva Medical, Inc. (USA) ; UK Medical (UK) ; and Xenogenics Corporation (USA).
Global stents market is analyzed from 2005 -2015, while estimations and predictions for the biodegradable stents market are provided for 2015-2020. The market is graphically represented for geographic regions including North America, Europe, Asia-Pacific, and Rest of World (RoW). The report serves as a guide to the potential Biodegradable Stents market worldwide. Information related to product developments, partnerships, collaborations, and other strategic market updates is covered in the report.
For more information about this report, please visit: http://www.researchimpact.com/MIR035_BIODEGRADABLESTENTS.aspx
Customer Support: contactus(at)researchimpact(dot)com.
Phone: INDIA: +91 9676994272 / UK: 076-24-057837 for 24/7 online and offline support
About RI Technologies
RI Technologies , http://www.researchimpact.com, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.